Filing Details

Accession Number:
0001209191-21-050979
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-08-11 18:23:30
Reporting Period:
2021-08-09
Accepted Time:
2021-08-11 18:23:30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1653087 Alector Inc. ALEC Biological Products, (No Disgnostic Substances) (2836) 462702363
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1757964 Robert Paul C/O Alector, Inc.
131 Oyster Point Blvd, Suite 600
South San Francisco CA 94080
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-08-09 9,691 $8.16 244,010 No 4 M Direct
Common Stock Acquisiton 2021-08-09 8,734 $10.14 252,744 No 4 M Direct
Common Stock Acquisiton 2021-08-09 4,525 $17.15 257,269 No 4 M Direct
Common Stock Disposition 2021-08-09 22,650 $27.17 234,619 No 4 S Direct
Common Stock Disposition 2021-08-09 300 $27.79 234,319 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2021-08-09 9,691 $0.00 9,691 $8.16
Common Stock Employee Stock Option (right to buy) Disposition 2021-08-09 8,734 $0.00 8,734 $10.14
Common Stock Employee Stock Option (right to buy) Disposition 2021-08-09 4,525 $0.00 4,525 $17.15
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
81,000 2028-07-02 No 4 M Direct
31,250 2028-11-06 No 4 M Direct
84,450 2029-11-06 No 4 M Direct
Footnotes
  1. The sales reported by the reporting person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 28, 2020.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.71 to $27.67, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.71 to $27.83, inclusive.
  4. Shares subject to the option vest in 48 equal monthly installments beginning on August 2, 2018.
  5. One-fourth of the total number of shares subject to the option grant vested on November 1, 2019, and an additional 1/48th of the shares subject vest monthly thereafter.
  6. Shares subject to the option vest in 48 equal monthly installments beginning on December 6, 2019.